Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
Clovis Oncology reports 2021 executive compensation
By ExecPay News
Published: April 27, 2022
Clovis Oncology reported fiscal year 2021 executive compensation information on April 27, 2022.
In 2021, five executives at Clovis Oncology received on average a compensation package of $1.5M, a 13% decrease compared to previous year.
Average pay of disclosed executives at Clovis Oncology
Patrick J. Mahaffy, Chief Executive Officer, received $2.6M in total, which decreased by 18% compared to 2020. 71% of Mahaffy's compensation, or $1.9M, was in option awards. Mahaffy also received $739K in salary and $22K in other compensation.
For fiscal year 2021, the median employee pay was $246,936 at Clovis Oncology. Therefore, the ratio of Patrick J. Mahaffy's pay to the median employee pay was 11 to one.
Lindsey Rolfe, Chief Medical Officer, received a compensation package of $1.2M, which decreased by 10% compared to previous year. 43% of the compensation package, or $536K, was in salary.
Gillian C. Ivers-Read, EVP and Chief Regulatory Officer, earned $1.2M in 2021, a 11% decrease compared to previous year.
Paul E. Gross, General Counsel, received $1.2M in 2021, which decreases by 11% compared to 2020.
Daniel W. Muehl, Chief Financial Officer, earned $1.2M in 2021, a 11% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 27, 2022.